Drug Candidate vs. Therapeutic Candidate
...
Explainers
Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
Theripio Innovations (the startup)
**What it means:** Theripio Innovations is the **startup company** founded by Dr. Christopher Cowan at MUSC to commercialize the MEF2C RNA therapeutic platform. In drug development, when academic rese...
MicroRNA Therapeutic Advantage (why MUSC chose RNA over gene therapy)
**What it means:** The MUSC team evaluated multiple approaches (gene therapy, micro-RNA therapeutics) and chose the RNA-based approach because it "offered several advantages." These likely include: - ...
MicroRNA (in the context of MHS RNA therapeutics)
MicroRNAs are tiny RNA molecules (about 22 nucleotides long) that regulate gene expression after transcription. They can bind to mRNA molecules and either block them from being translated into protein...
AAV (Adeno-Associated Virus)
**What it means:** AAV is a tiny, harmless virus used as a **delivery vehicle** (vector) to carry therapeutic genes into cells. Think of it like a Trojan horse — the virus looks normal from the outsid...
Serotype (AAV Serotype)
**What it means:** AAV isn't a single virus — it's a family of related viruses, each called a **serotype**. Different serotypes have different **tissue preferences** — some are better at reaching the ...
Base Editing
**What it means:** Base editing is a precise gene-editing technique that changes a single DNA letter (like turning an A into a G) without cutting both strands of the DNA helix (which is how traditiona...
KRAS Mutation and RASopathies
**What it means:** KRAS is one of the most commonly mutated genes in cancer. "RASopathies" are a group of genetic conditions caused by mutations in the RAS signaling pathway (which includes genes like...